Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathy
- 1 June 2012
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 26 (3), 325-337
- https://doi.org/10.1016/j.beem.2011.11.005
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated OrbitopathyJournal of Clinical Endocrinology & Metabolism, 2011
- Graves' OphthalmopathyNew England Journal of Medicine, 2009
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GOActa Endocrinologica, 2008
- An Optimal Treatment for Pediatric Graves’ Disease Is RadioiodineJournal of Clinical Endocrinology & Metabolism, 2007
- Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchersActa Endocrinologica, 2006
- Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessmentClinical Endocrinology, 2001
- Management of Graves' Ophthalmopathy: Reality and PerspectivesEndocrine Reviews, 2000
- Ablative or non-ablative therapy for Graves’ hyperthyroidism in patients with ophthalmopathy?Journal of Endocrinological Investigation, 1998
- Preventing Graves' OphthalmopathyNew England Journal of Medicine, 1998
- Clinical activity score as a guide in the management of patients with Graves' ophthalmopathyClinical Endocrinology, 1997